Fundraising, Capital Access Window & Trading Halt

Seed Innovations Limited

22 September 2026

 

7.00am 22 September 2026

SEED Innovations Limited
("SEED" or the "Company")

Fundraising, Capital Access Window & Trading Halt

Fundraising

Following the adoption of its revised investing strategy in 2025 focused on identifying and investing in high-growth physical AI and robotics companies at an early stage of commercialisation, SEED has completed three investments. It is now announcing its intention to raise additional capital through an issue of new securities (the "Proposed Fundraising") to pursue further opportunities in the sector and provide capacity for follow-on investment in selected existing portfolio companies.

Capital Access Window

The Company wishes to announce that, following the recent amendments to the AIM Rules for Companies, it intends to utilise the newly introduced Capital Access Window facility in connection with the Proposed Fundraising. 

The AIM Rules Capital Access Window facility provides the Company with a voluntary mechanism to implement a temporary pause in trading in its securities. The Company has elected to utilise this facility in order to achieve pricing stability during the Proposed Fundraising.

Accordingly, trading in the Company's Ordinary Shares will enter a Capital Access Window trading halt with effect from 7.30 a.m. today. The Company will provide a further announcement in due course.

ENDS

For further information on SEED please visit: www.seedinnovations.co or contact: 

Lance de Jersey	SEED Innovations Ltd	E: [e-mail]
James Biddle  Roland Cornish	Beaumont Cornish Limited,  Nomad	T: [phone]
Isabella Pierre  Damon Heath	Shard Capital Partners LLP  Broker	T: [phone]
Ana Ribeiro Isabel de Salis	St Brides Partners Ltd,  Financial PR	E: [e-mail]

NOTES 

SEED Innovations Ltd – https://www.seedinnovations.co

SEED Innovations Ltd (AIM: SEED) is an investing company focused on providing access to high-growth robotics and AI ventures typically beyond the reach of everyday investors. The Company also oversees a legacy portfolio in wellness and life sciences, with a medium-term strategy to unlock its full value.

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Nominated Adviser statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company’s Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish’s responsibilities as the Company’s Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and the AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for, and will not be responsible to, any other person for providing the protections afforded to customers of Beaumont Cornish, nor for advising them in relation to the arrangements described in this announcement or any matter referred to herein.

 

END